Aktien Sensor

Straumann Holding AG has made significant investments in Asia, relocating production to Shanghai and aiming to capitalize on growing demand for dental implants in the region.

Sonova Holding AG has announced a 2.33% increase in its gross dividend to CHF 4.40 per share, a move that is expected to please investors but should be viewed with caution.

Coloplast A/S, a leading healthcare equipment company, is navigating market volatility but remains optimistic about its long-term growth prospects in the global medical tapes and bandages market.

Philips’ stock price has declined due to market volatility, but the company remains well-positioned for growth in the healthcare sector, driven by increasing demand for home-based care and diagnostic services.

Amgen’s presentation at the Goldman Sachs conference comes as the broader market experiences a welcome uptrend, with the Dow Jones index rising 0.964% since the start of 2025.

Neurocrine Biosciences has strengthened its leadership with the strategic appointment of Lewis Choi as Chief Information Officer, positioning the company for continued growth and success.

Incyte has announced multiple presentations at the European Hematology Association (EHA) 2025 conference, including new data for its mutCALR-Directed Monoclonal Antibody.

Intuitive Surgical’s stock price has plummeted due to a rare ‘Sell’ rating from Deutsche Bank, sparking concerns about the company’s future performance.

Grifols SA has made significant strides in the biopharmaceutical industry, securing a worldwide license for a new treatment technology and making strategic investments in the biotechnology sector.

Becton Dickinson & Co’s stock price has been stagnant, with a moderate valuation and stable price movement, but its potential for future growth remains uncertain.